GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (OTCPK:CMVLF) » Definitions » E10

Cellectis (Cellectis) E10 : $-2.28 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Cellectis E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cellectis's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.700. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.28 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-05), Cellectis's current stock price is $2.60. Cellectis's E10 for the quarter that ended in Dec. 2023 was $-2.28. Cellectis's Shiller PE Ratio of today is .


Cellectis E10 Historical Data

The historical data trend for Cellectis's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellectis E10 Chart

Cellectis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -2.13 -2.19 -2.28

Cellectis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.19 -2.35 -2.30 -2.80 -2.28

Competitive Comparison of Cellectis's E10

For the Biotechnology subindustry, Cellectis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cellectis's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellectis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cellectis's Shiller PE Ratio falls into.



Cellectis E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cellectis's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.7/118.2300*118.2300
=-0.700

Current CPI (Dec. 2023) = 118.2300.

Cellectis Quarterly Data

per share eps CPI Adj_EPS
201306 -1.119 99.700 -1.327
201312 0.000 99.800 0.000
201406 0.000 100.180 0.000
201412 0.000 99.860 0.000
201503 0.206 100.170 0.243
201506 -0.707 100.440 -0.832
201509 -0.405 99.950 -0.479
201512 0.251 100.040 0.297
201603 -0.952 100.020 -1.125
201606 -0.200 100.630 -0.235
201609 -0.400 100.340 -0.471
201612 -0.368 100.650 -0.432
201703 -0.560 101.170 -0.654
201706 -0.750 101.320 -0.875
201709 -0.730 101.330 -0.852
201712 -0.760 101.850 -0.882
201803 -0.710 102.750 -0.817
201806 -0.170 103.370 -0.194
201809 -0.540 103.560 -0.616
201812 -0.530 103.470 -0.606
201903 -0.360 103.890 -0.410
201906 -0.790 104.580 -0.893
201909 -0.380 104.500 -0.430
201912 -0.880 104.980 -0.991
202003 0.470 104.590 0.531
202006 -0.760 104.790 -0.857
202009 -0.710 104.550 -0.803
202012 -0.950 104.960 -1.070
202103 -0.280 105.750 -0.313
202106 -0.880 106.340 -0.978
202109 -0.820 106.810 -0.908
202112 -0.950 107.850 -1.041
202203 -0.700 110.490 -0.749
202206 -0.420 112.550 -0.441
202209 -0.630 112.740 -0.661
202212 -0.590 114.160 -0.611
202303 -0.580 116.790 -0.587
202306 -0.190 117.650 -0.191
202309 -0.310 118.260 -0.310
202312 -0.700 118.230 -0.700

Add all the adjusted EPS together and divide 10 will get our e10.


Cellectis  (OTCPK:CMVLF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cellectis E10 Related Terms

Thank you for viewing the detailed overview of Cellectis's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cellectis (Cellectis) Business Description

Traded in Other Exchanges
Address
8, rue de la Croix Jarry, Paris, FRA, 75013
Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. It reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.